A National Survey of Medical Students’ Beliefs and Knowledge in Screening for Prostate Cancer by Marcella, Stephen et al.
A National Survey of Medical Students’ Beliefs and Knowledge
in Screening for Prostate Cancer
Stephen Marcella, MD, MPH
1,2, Cristine D. Delnevo, PhD, MPH
1, and Steven S. Coughlin, PhD
3
1Department of Epidemiology( UMDNJ-School of Public Health, 683 Hoes Lane West, Piscataway, NJ 08854, USA;
2Robert Wood Johnson
Medical School, Piscataway, NJ, USA;
3Centers for Disease Control and Prevention, Atlanta, GA, USA.
BACKGROUND: Today’s medical students are being
educated at a time when there are no evidence-based
guidelines for prostate cancer screening.
OBJECTIVE: To examine medical students’ knowledge
and beliefs concerning prostate cancer screening and
speciﬁc determinants for their beliefs.
DESIGN, SETTING, AND PARTICIPANTS: One thou-
sand six hundred and forty four students were sampled
at 20 medical schools using a web-based, cross-sec-
tional survey.
MAIN OUTCOME MEASURES: Basic knowledge and
beliefs about prostate cancer testing, epidemiology, and
therapy were ascertained.
RESULTS: Four of 8 knowledge items were answered
incorrectly by 50% or more of students. Seven of
8 students believe that early diagnosis from screening
can improve survival from prostate cancer. Second- and
third-year students were more likely than fourth-year
students to believe that the digital rectal exam (DRE)
and the prostate-speciﬁc antigen test were accurate,
adjusted odds ratio (AOR) 1.8; 95% conﬁdence interval
(CI), 1.2 to 2.7 and 1.7; 1.3 to 2.2 for second and third
years, respectively, for the DRE. Black and Hispanic
students were no more likely than white students to
agree that early screening diagnosis improves survival,
but blacks were more likely to agree with screening
black or Hispanic men (AOR 7.8; 95% CI, 5.3 to 11.4
and 3.2; 2.2 to 4.7, respectively). More knowledgeable
students were less likely to believe in the beneﬁt of early
detection and the accuracy of the prostate-speciﬁc
antigen (AOR 0.3; 95%CI, 0.2 to 0.5).
CONCLUSIONS: Medical students generally are very
optimistic about the beneﬁts of screening for prostate
cancer. Increased knowledge about prostate cancer is
associated with a more conservative view of screening.
Other predictors are independent of this knowledge.
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rostate cancer is particularly common among elderly men
and is the second-leading cause of cancer deaths among
men. Currently, there is no available evidence from random-
ized trials that early detection of prostate cancer improves
health outcomes, but the prostate-speciﬁc antigen (PSA) test is
commonly used to screen men for prostate cancer.
1,2 Findings
support the PSA test’s ability to detect early-stage prostate
cancer,
3 but whether it should be used for screening continues
to be debated.
4,5 Those who advocate for early, more aggressive
screening claim that early detection and therapy saves lives
and decreases associated morbidity. Others state that al-
though therapy may be modestly effective, this has not been
proven in the context of screening, and many men identiﬁed
with prostate cancer may not beneﬁt from therapy but could be
harmed. Consequently, prostate cancer screening remains a
contentious topic as illustrated by the range of recommenda-
tions from different medical organizations.
4,6
Much of what a physician decides to discuss with the
patient is predicated on various provider- and patient-related
factors.
7–9 Though little research exists to explain what
inﬂuences physicians to recommend a PSA test, some factors
known to be associated with screening in general include
physician knowledge and beliefs, physician specialty and
practice style, patient attitudes and values, patient demo-
graphics, and clinical guidelines.
9–13 Factors inﬂuencing can-
cer screening may be formulated prior to and during a
physician’s training and may differ by race or ethnicity, age,
gender, and orientation towards primary care.
7,14,15 Accord-
ingly, medical students are an important population to study
the determinants of screening for prostate cancer.
METHODS
Sample
We employed a 2-stage, stratiﬁed, cluster design to obtain a
nationally representative sample of U.S. medical students.
Institutional review boards at the University of Medicine and
Dentistry of New Jersey–School of Public Health and the
Centers for Disease Control and Prevention approved the study.
In the ﬁrst stage, we sampled medical schools; the frame was
constructed from the Association of American Medical College
Institutional Proﬁle System (1998–1999) and was stratiﬁed by
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80minority enrollment. Twenty-eight medical schools were select-
ed, and medical schools with a high proportion of minority
enrollment were oversampled. Of these 28 schools, 20 (71%)
agreed to participate.
The second stage sampled students from within each
participating medical school. Thirty students were chosen at
random from within each class year, except for fourth-year
students, whom we oversampled (50 students) to facilitate a
follow-up study (not discussed herein). Of 2,954 sampled
students, 1,644 (56%) participated. Thirty-ﬁve responses were
not included in the analysis because of suspected duplicates
and/or partially completed surveys, resulting in a ﬁnal sample
of 1,609. Response rates by class year were consistent (55%,
59%, 51%, and 51%). The overall response rate (school ×
student rate) was 40%.
Data Collection and Administration
Many studies of medical students have used convenience
samples from single institutions, and response rates have
varied considerably across class years, with lower rates noted
among third- and fourth-year students.
16,17 In view of such
concerns, we used a web-based method of data collection
allowing us to survey students who may be off-campus. We
randomly selected students via an introductory e-mail, and
completed surveys were electronically transmitted to the study
investigators. No personal identiﬁers were requested. E-mail
reminders and incentives were employed to enhance student
response rates. The survey was administered during the 2001
academic year.
We developed the instrument based on previous studies
associating various characteristics of residents and medical
students with their attitudes towards disease prevention.
Variables included demographic descriptors,
14,16,18–21 special-
ty orientation,
14,18–20 family experience with disease,
20 class
year,
21 and knowledge of prostate cancer screening, epidemi-
ology, and treatment.
10,12
Knowledge
Students responded to a list of 8 true/false statements
previously employed by Austin and colleagues.
12 There is no
“unsure” choice in this instrument. The items address com-
mon facts about prostate cancer screening, treatment, and
epidemiology. Two statements assess students’ awareness of
the American Cancer Society (ACS) and the United States
Preventive Services Task Force (USPSTF) recommendations
(circa 2000) on screening for prostate cancer. Scores were
categorized by the number of correct responses as low (0–3,
17% of total), middle (4–5, 51% of total), or high (≥6, 32% of
total) scores.
Beliefs
Our main outcomes are students’ overall belief in the beneﬁts
of early detection and the accuracy of screening with a digital
rectal exam (DRE) and PSA testing. We adapted 3 items from a
survey developed by Hoffman et al.
10 Screening belief state-
ments use the word “accurate” to connote an overall sense of
the strength of the tests in contrast to knowledge statements
that have deﬁnitive, correct responses. Three additional state-
ments examine the level of support for screening speciﬁc
subpopulations: men with a family history of prostate cancer,
black men, and Hispanic men. Agreement with statements was
graded using a 5-point Likert scale.
Analysis
The data set was weighted for the varying probability of
selection for each school and class year. Statistical analyses
were performed using SUDAAN (Research Triangle Institute,
Research Triangle Park, NC, USA), which adjusts standard
errors for the complex sample design. Point estimates with
95% conﬁdence intervals were used for descriptive analyses.
We considered a P value of ≤0.05 as signiﬁcant. We con-
structed separate, multivariate logistic regression models for
each belief in Table 3. We classiﬁed “agree strongly” and “agree
somewhat” as a positive response, and “no opinion,”“ disagree
somewhat,” and “disagree strongly” as a negative response. We
obtained adjusted odds ratios (AORs) for each belief with
variables identiﬁed a priori as being possibly predictive: sex,
race or ethnicity, age, class year, future specialty orientation,
family history of prostate cancer, and knowledge score result
from Table 2. We also modeled a composite outcome in which a
positive result was deﬁned as responding afﬁrmatively to all of
the ﬁrst 3 screening statements in Table 3. The models were
run with and without knowledge scores to see if this mediated
any of the other associations with belief outcomes.
RESULTS
Weighted percentages for sex, race or ethnicity, class year,
specialty orientation, and family history of cancer are shown in
Table 1. The weighted composition by sex and race or ethnicity
is comparable to overall national statistics for U.S. medical
students.
22
Knowledge about prostate cancer and prostate cancer
screening by class year is shown in Table 2. Approximately
half of all students incorrectly thought that there was evidence
Table 1. Characteristics of U.S. Medical Student Participants
(N=1,609)
Percent (n*)
Sex
Male 56.9 (805)
Female 43.1 (804)
Race/ethnicity
White 64.5 (1,100)
Asian 16.6 (248)
Black 7.7 (118)
Hispanic 6.6 (51)
Other 4.4 (88)
Class year
First 25.4 (369)
Second 24.6 (390)
Third 25.4 (346)
Fourth 24.6 (504)
Career orientation
Specialist 44.5 (670)
Generalist 39.8 (717)
Do not know 15.7 (219)
Family history of cancer
Prostate 10.3 (172)
Any other cancer 61.1 (1,034)
*Unweighted n.
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PSA testing and that the mortality rate from prostate cancer
had not decreased in recent years. Most (89.5%) were unaware
that USPSTF guidelines do not recommend screening for
prostate cancer. Two-thirds thought (incorrectly at the time)
that there was evidence for the efﬁcacy of radical prostatecto-
my for improving survival (the study showing a reduction in
prostate cancer–related deaths after prostatectomy was not yet
published.
23 For 5 of the 8 knowledge items in Table 2, there
was progression toward a greater percentage of correct
answers by advancing year. Few differences in knowledge were
noted by sex, specialty orientation, or race/ethnicity (data not
shown).
Nearly 90% of students agreed strongly or somewhat that an
early diagnosis by screening can improve survival from
prostate cancer (Table 3). When questioned speciﬁcally about
the accuracy of the DRE or the PSA test for screening, 62.8%
and 54.8% of the students, respectively, agreed either strongly
or somewhat that they were accurate. Students were more
likely to favor screening in context of a positive family history
(83.4%) but were less certain if the patient was black or
Hispanic (46.7% and 61.1% with no opinion, respectively).
In a series of logistic regression models (Table 4), we
modeled each of the 6 screening beliefs as a function of the
students’ characteristics. Age was highly correlated with class
year and it was dropped from the models. Sex was not sig-
niﬁcantly associated with any of the beliefs. Specialty-oriented
students had nearly twice the odds of those oriented toward
primary care of agreeing that early screening improves survival
(P = .005). In contrast, Asian students and those scoring high
in knowledge were more likely to have a negative response
(AOR of 0.6, P = .01, and AOR of 0.2, P < .0001, respectively).
With regard to the belief about the accuracy of the DRE,
second- and third-year students hadgreater oddsof responding
afﬁrmatively than fourth-year students (AORs of 1.8, P = .005
and 1.7, P = .002, respectively), while students scoring high in
knowledge were more likely to respond negatively (AOR of 0.6,
P = .017). Similar associations were noted for PSA test accura-
cy, except high-knowledge score students had an even lower
AOR of 0.3 (P < .0001). Additionally, both specialty orientation
(AOR of 1.5, P = .01) and a student’s family history of prostate
cancer (AOR of 1.7, P = .008) were positively associated with
this belief.
The odds of responding positively to all of the ﬁrst 3 beliefs
for second- and third-year students were almost twice that of
fourth-year students (P = .003 and <.0001, respectively).
Specialty and knowledge associations were also signiﬁcant
with AORs of 1.4 and 0.3 (P = .02 and <.0001, respectively).
There were also some very signiﬁcant differences in
responses to the statements measuring the strength of belief
in PSA screening of speciﬁc populations. For patients having a
Table 2. Percentage of U.S. Medical Students Correctly Responding
to Statements About Prostate Cancer Screening by Class Year
(N=1,609)
Class year Total
First Second Third Fourth
The mortality rate for
prostate cancer has
not declined in recent
years (F)
50.3 49.7 48.2 46.2 48.6
Prostatectomy results in
improved survival over
the natural course of
the disease (F)*
20 33.4 41.9 47.1 35.5
ACS recommends routine
prostate cancer
screening for all men
over age 50 (T)
91.2 90.2 89.5 91.4 90.6
A normal PSA level rules
out prostate cancer. (F) 86.3 93.5 92.1 92.6 91.1
Randomized control trials
have clearly supported
PSA prostate cancer
screening. (F)
25.3 45.7 59.9 69.2 49.9
Elevated PSA levels
almost always indicate
a diagnosis of prostate
cancer (F)
58.4 78.5 90.6 90.3 79.4
USPSTF recommends
routine prostate cancer
screening for all men
over age 50 (F)
4.6 5.3 14.6 17.7 10.5
The PSA test is highly
speciﬁc in prostate
cancer screening (F)
58.9 78.1 81 80.8 74.6
N=1,609: unweighted N.
ACS American Cancer Society, PSA prostate-specific antigen, USPSTF
United States Preventive Services Task Force, F the statement is factually
false, T the statement is factually true.
*At the time of the study, evidence in support of prostatectomy did not exist.
Table 3. Beliefs Towards Prostate Cancer Screening Among U.S. Medical Students (N=1,609)
Agree
strongly %
Agree
somewhat %
No
opinion %
Disagree
somewhat %
Disagree
strongly %
An early screening diagnosis can improve
survival for men with prostate cancer 61.1 26.5 4.1 7.4 0.8
The digital rectal examination is an
accurate screening test for prostate cancer 11.3 51.5 13.5 19.8 3.9
The PSA test is an accurate screening test
for prostate cancer 11.5 43.3 18.3 21.8 5.2
More likely to screen if a patient has a
family history of prostate cancer 53.1 30.3 7.1 5.9 3.7
More likely to screen for prostate cancer if
a patient is black 18.4 16.9 46.7 10.7 7.4
More likely to screen for prostate cancer if
a patient is Hispanic 3.6 11.6 61.1 14.9 8.8
N=1,609: unweighted N.
PSA prostate-specific antigen.
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odds of agreement with screening compared to fourth-year
students (P = .019). Students scoring highest in knowledge
were less likely to agree (AOR of 0.6, P = .013). Marked
differences by student’s race/ethnicity were seen for beliefs in
screening black and Hispanic men. Black students had 7.8
and 3.2 times the odds of agreement with being more likely to
screen these respective groups relative to white students
(P < .0001 for both comparisons). Hispanic students were also
in greater agreement with being more likely to screen Hispanic
men (AOR of 2.3, P = .03) but not black men.
When the models were examined without knowledge cate-
gories (not shown), there was almost no change in the AORs of
the other covariates, indicating the absence of confounding or
mediation by knowledge on these other factors.
COMMENT
In much the same manner that medical educators have to
teach students about the nuances and uncertainties of
prostate cancer screening, future physicians will eventually
have to integrate this imperfect knowledge in communicating
to their patients. To our knowledge, this is the ﬁrst national
sample of medical students in the United States who have been
surveyed regarding their beliefs and knowledge concerning this
controversial screening modality. Zapka and colleagues exam-
ined cancer knowledge and attitudes, but their sample was
taken from 1 medical school, and they did not examine pos-
sible predictors of the attitudes or beliefs.
21
Perhaps our most important ﬁnding is that medical stu-
dents overwhelmingly believe that early detection of prostate
cancer through screening improves survival. Moreover, most
students agreed that the DRE and the PSAwere accurate tests.
While a belief in their accuracy does not necessarily imply a
belief that these tests can increase survival, nearly half of
second- and third-year students agreed with all of the ﬁrst 3
screening belief statements (improving survival, accuracy of
DRE and PSA); even 30% of fourth-year students agreed.
This survey also measured medical students’ knowledge
regarding prostate cancer screening and the change in this
knowledge by class year. We detected signiﬁcant improvement
by class year for some items, but not for others. Students fared
most poorly on knowledge of recent epidemiology of prostate
cancer and evidence for or against efﬁcacy studies of prosta-
tectomy and the PSA test. Interestingly, most students did
know that the ACS recommends PSA screening, but did not
know that the USPSTF (2000) does not recommend PSA
screening. However, it is possible that students just assumed
that both organizations would recommend such a test without
actual knowledge of their policies.
Beliefs reﬂect one’s perceptions or assumptions about
reality and can vary from individual to individual, whereas
knowledge is grounded in facts. We suspected that students’
factual knowledge of prostate cancer and performance char-
acteristics of the PSA test would affect their beliefs about
screening. We found this to be true as “high-knowledge”
students were signiﬁcantly less likely to agree with all 3 of the
screening beliefs. In other words, increased knowledge was
associated with a less optimistic stance towards prostate
cancer screening.
Table 4. Characteristics Associated With Prostate Cancer Screening Beliefs Among U.S. Medical Students
Early screening
improves survival
DRE is an
accurate
screening test
PSA is an
accurate
screening test
More likely to screen if
patient has family
history
More likely to
screen if patient is
black
More likely to screen
if patient is Hispanic
AOR (95%CI) AOR (95%CI) AOR (95%CI) AOR (95%CI) AOR (95%CI) AOR (95%CI)
Sex
Male 1.00 (referent) 1.00 (referent) 1.00 (referent) 1.00 (referent) 1.00 (referent) 1.00 (referent)
Female 1.37 (0.81–2.31) 0.96 (0.64–1.45) 0.85 (0.70–1.04) 1.04 (0.78–1.39) 1.15 (0.80–1.66) 1.15 (0.81 –1.64)
Medical school year
First 1.33 (0.68–2.63) 0.80 (0.57–1.13) 0.54 (0.36–0.81) 0.98 (0.66–1.45) 0.21 (0.13–0.36) 0.63 (0.32–1.26)
Second 1.05 (0.65–1.70) 1.82 (1.24–2.69) 1.70 (1.09–2.64) 1.98 (1.14–3.43) 0.60 (0.38–0.95) 1.06 (0.52–2.15)
Third 1.36 (0.87–2.13) 1.66 (1.25–2.20) 1.40 (0.93–2.13) 1.52 (0.99–2.34) 1.01 (0.67–1.53) 1.28 (0.85–1.92)
Fourth 1.00 (referent) 1.00 (referent) 1.00 (referent) 1.00 (referent) 1.00 (referent) 1.00 (referent)
Future practice intention
Primary care 1.00 (referent) 1.00 (referent) 1.00 (referent) 1.00 (referent) 1.00 (referent) 1.00 (referent)
Specialty 1.93 (1.27–2.95) 1.18 (0.88–1.59) 1.45 (1.11–1.90) 0.85 (0.62–1.15) 0.84 (0.68–1.05) 0.88 (0.56–1.40)
Do not know 1.20 (0.68–2.09) 0.90 (0.62–1.32) 1.14 (0.69–1.88) 0.65 (0.35–1.23) 0.86 (0.59–1.26) 1.13 (0.60–2.13)
Race/ethnicity
White 1.00 (referent) 1.00 (referent) 1.00 (referent) 1.00 (referent) 1.00 (referent) 1.00 (referent)
Asian 0.58 (0.38–0.88) 0.98 (0.72–1.34) 0.83 (0.66–1.05) 1.39 (0.89–2.17) 0.69 (0.50–0.97) 1.16 (0.70–1.93)
Black 0.82 (0.33–2.03) 0.95 (0.57–1.58) 1.60 (0.98–2.60) 0.89 (0.50–1.58) 7.80 (5.32–11.43) 3.19 (2.17–4.69)
Hispanic 1.20 (0.45–3.20) 0.78 (0.46–1.33) 1.08 (0.69–1.70) 0.75 (0.19–2.95) 1.58 (0.64–3.86) 2.30 (1.10–4.83)
Other 0.79 (0.38–1.67) 1.87 (0.97–3.61) 0.81 (0.48–1.37) 0.88 (0.47–1.62) 1.52 (0.81–2.85) 2.09 (0.88–4.93)
Family history of prostate cancer
No 1.00 (referent) 1.00 (referent) 1.00 (referent) 1.00 (referent) 1.00 (referent) 1.00 (referent)
Yes 1.03 (0.53–2.02) 0.94 (0.65–1.35) 1.73 (1.18–2.54) 1.60 (0.75–3.40) 1.24 (0.88–1.75) 1.46 (0.98–2.16)
Knowledge*
Low 1.00 (referent) 1.00 (referent) 1.00 (referent) 1.00 (referent) 1.00 (referent) 1.00 (referent)
Middle 0.62 (0.35–1.10) 0.94 (0.57–1.55) 0.72 (0.51–1.03) 0.60 (0.33–1.06) 0.79 (0.62–1.00) 0.74 (0.49–1.12)
High 0.21 (0.14–0.34) 0.57 (0.37–0.89) 0.34 (0.22–0.52) 0.55 (0.35–0.87) 0.72 (0.45–1.15) 0.70 (0.46–1.07)
DRE digital rectal exam, PSA prostate-specific antigen, AOR adjusted odds ratio, CI confidence interval.
*Assignment by number of statements correctly addressed in Table 2: low 0–3, middle 4–5, and high 6–8.
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agreement with the ﬁrst 3 screening beliefs, either individually
or collectively, did not change signiﬁcantly with the addition of
knowledge scores. Indeed, the AORs for race/ethnicity, spe-
cialty orientation, and family history of prostate cancer
changed very little after knowledge was added to the model,
suggesting that these characteristics reﬂect feelings and
attitudes more resistant to change. A student with a family
member diagnosed with prostate cancer may be more willing to
believe in the accuracy of a PSA test. Similarly, it is interesting
to speculate why students oriented to a specialty are more
optimistic about early screening and, to a lesser extent, the
accuracy of the PSA test. Perhaps students who are more
attracted to procedures or active intervention are more opti-
mistic or, alternatively, those interested in primary care are
more skeptical (or realistic?) of what modern medicine can do.
It would be interesting for future research to see if this more
aggressive approach to screening is present in specialist
physicians who also practice primary care, as compared to
traditional primary care practitioners.
Student race had a very large effect on prostate cancer
screening beliefs towards black and Hispanic men. That black
students were also more likely to screen Hispanic men—a
subgroup that has not been shown to have a higher risk than
white men—suggests that these students may perceive that
minorities, in general, are more vulnerable to prostate cancer.
Clinician-teachers should be aware of these perceptions—
especially as they may inﬂuence the use of tests that have no
ﬁrm guidelines. Future physicians should be taught to under-
stand that their perceptions may not be based on evidence,
and that they need to remain open and keep informed about
new ﬁndings on the utility of speciﬁc screening programs.
The effect of class year on screening beliefs is interesting.
Initially, the observation that ﬁrst-year students are less likely
to believe in PSA seems puzzling, but closer examination of the
responses reveals that this was due more to the absence of
opinion (49.8%) rather than actual disagreement. Why are
second- and third-year students more likely to believe that the
DRE and PSA tests are accurate than fourth-year students,
even after accounting for knowledge? The general public is very
optimistic about cancer screening in general,
24 and this is
probably representative of beginning students as well. It is not
until their third and fourth years that students have signiﬁ-
cant outpatient exposure to screening in practice. This expe-
rience most likely tempers the initial enthusiasm for prostate
cancer screening. This should be reassuring to medical school
faculty; it demonstrates that attitudes and beliefs continue to
be formed throughout the medical school experience. Changes
in beliefs by class year occur independently of knowledge,
suggesting that other factors are operative, such as the im-
portance of role models in the clinical years. Future research
should focus on the “durability” of these beliefs into residency
and practice.
These ﬁndings have important implications for those re-
sponsible for teaching medical students about subject matter
that has no deﬁnite guidelines. First, medical students, on
average, have an exaggerated belief in the accuracy of these
screening tests. This may carry over into residency and
practice, leading to “overselling” the value of prostate cancer
screening to the average-risk patient. Medical educators must
inculcate a perspective that acknowledges a possible beneﬁto f
screening while understanding that it may also have draw-
backs such as overdiagnosis, labeling, and initiation of costly
and potentially harmful treatments without necessarily in-
creasing survival.
5 Finally, students should be taught to
become self-aware of perceptions that may not be evidence-
based but may interfere with incorporating new ﬁndings into
their practice.
A limitation of our study is its cross-sectional design. Even
so, the ﬁndings by class year have signiﬁcant point estimates,
and the graded progression through class years suggests a
causal relationship between educational experience and stu-
dent beliefs. A second limitation is our response rate: for
students, it was 56%. A response bias is possible, but we could
not analyze nonresponders. Our instrument to assess knowl-
edge was an 8-item true/false questionnaire. By forcing a
discrete yes or no answer, we have not obtained information
about those students who were unsure of their answers.
However, by “forcing” a categorization, we have described those
that are “leaning to” a particular answer, thus still providing
some value as a determinant. At the time of the survey, few
validated questionnaires about prostate cancer knowledge
existed, and none were designed for medical students. Several
new knowledge assessment instruments have since become
available, including the most recent one by Bell,
25 but again,
none speciﬁcally for students. Finally, this survey was admin-
istered in 2000–2001, before Thompson revealed that prostate
cancer is indeed common in men with PSA ≤4.0 ng/ml,
26
calling into question the traditional threshold for performing a
biopsy, and prior to studies showing a beneﬁcial effect of
prostatectomy on mortality.
23,27 These well-publicized reports
could inﬂuence today’s medical students’ beliefs in ways not
reﬂected in our student sample.
A signiﬁcant strength of the study is that we oversampled
schools with a high proportion of minority students. This
approach allowed us to study associations of race/ethnicity with
screening beliefs. In addition, our web-based design provided an
environment that allowed thoughtfulness for responses.
28
To summarize, we have demonstrated in a national sample
of medical students that misperceptions and inaccuracies
about prostate cancer are common but improve somewhat
with class year. Overall, students are very optimistic in per-
ceiving a beneﬁt from prostate cancer screening, but a
moderate amount of knowledge about screening, treatment,
and the epidemiology of prostate cancer substantially
decreases the degree of optimism. Finally, we show that there
are speciﬁc predictors of screening beliefs that are independent
of the students’ knowledge about this cancer.
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